Company Ticker News August 8, 20213 Big Dividends, Paying Monthly, For Your Retirement Basea 0 0 Share
Press Release August 4, 2021JAMA Dermatology Publishes Data Showing RINVOQ® (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis 0 0 Share
Company Ticker News August 3, 2021Kiplinger Outstanding August Dividend Dogs Feature 9 Primed To Buy 0 0 Share
